HomeTagsGuided Therapeutics

Guided Therapeutics

LuViva Advanced Cervical Span Awarded New CE Mark with Expanded Claims

The new CE Mark includes expanded claims for the use of LuViva by physicians for the early detection of cervical cancer.

Guided Therapeutics Inc. Receives $2.5 Million Purchase Order from Chinese Partner Shandong Medical Device Technology Company

4/2/19: Guided Therapeutics Inc. reports the purchase order includes parts for final assembly of LuViva along with single use disposables that are consumed with each LuViva test. Approximately 25% of the purchase order will be paid upon Shandong’s filing with the Chinese FDA with the remainder due once Chinese FDA approval is obtained, which is expected within about one year.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version